ET Pharma

More US employers to drop weight-loss drugs in 2027, as healthcare costs increase

Aug 26, 2026, 2:20 AM

Translate article text

Choose a language and wait for the translated text.

Two-thirds of employers surveyed said they saw rising utilization of the drugs. GLP-1 weight-loss drugs, such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo.